These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28212180)

  • 1. Advances in the management of hyperkalemia in chronic kidney disease.
    Cowan AC; Gharib EG; Weir MA
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):235-239. PubMed ID: 28212180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
    Palmer BF
    Mayo Clin Proc; 2020 Feb; 95(2):339-354. PubMed ID: 31668450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P; Shah S; McAlister L; Cleghorn S; King L; Shroff R
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperkalemia treatment in chronic kidney disease patients: overview on new K binders and possible therapeutic approaches].
    De Stefano T; Borrelli S; Garofalo C; Provenzano M; De Nicola L; Minutolo R; Conte G
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium binding for conservative and preservative management of chronic kidney disease.
    Clegg DJ; Palmer BF
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):29-38. PubMed ID: 31714287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis.
    Zhang Y; Xu R; Wang F; Liu Y; Xu J; Zhao N; Cheng F; Long L; Jia J; Lin S
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1057-1066. PubMed ID: 33459923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent.
    Rastogi A; Hanna RM; Mkrttchyan A; Khalid M; Yaqoob S; Shaffer K; Dhawan P; Nobakht N; Kamgar M; Goshtaseb R; Sarmosyan K; Gnarini M; Wassef O; Lerma E
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1055-1064. PubMed ID: 34227913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalemia in the Hypertensive Patient.
    Lakkis JI; Weir MR
    Curr Cardiol Rep; 2018 Mar; 20(2):12. PubMed ID: 29492706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale.
    St-Jules DE; Clegg DJ; Palmer BF; Carrero JJ
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):467-472. PubMed ID: 34670798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies for hyperkalemia.
    Leon SJ; Harasemiw O; Tangri N
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):238-244. PubMed ID: 30865167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy.
    Sampani E; Theodorakopoulou M; Iatridi F; Sarafidis P
    Expert Opin Pharmacother; 2023; 24(16):1775-1789. PubMed ID: 37545002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia.
    Pitt B; Garza D
    Expert Opin Drug Saf; 2018 May; 17(5):525-535. PubMed ID: 29667438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to management of hyperkalaemia in kidney transplantation.
    Rizk J; Quan D; Gabardi S; Rizk Y; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):27-37. PubMed ID: 33027094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemia in chronic kidney disease.
    Watanabe R
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s31-s36. PubMed ID: 31939533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on medical management of hyperkalemia.
    Lopes MB; Rocha PN; Pecoits-Filho R
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):417-423. PubMed ID: 31268919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
    Valdivielso JM; Balafa O; Ekart R; Ferro CJ; Mallamaci F; Mark PB; Rossignol P; Sarafidis P; Del Vecchio L; Ortiz A
    Drugs; 2021 Sep; 81(13):1467-1489. PubMed ID: 34313978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing hyperkalemia in high-risk patients in long-term care.
    Kumar R; Kanev L; Woods SD; Brenner M; Smith B
    Am J Manag Care; 2017 Feb; 23(2 Suppl):S27-S36. PubMed ID: 28978211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Management of Hyperkalemia.
    Liu M; Rafique Z
    Curr Heart Fail Rep; 2019 Jun; 16(3):67-74. PubMed ID: 30972536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.